Bio-Techne (TECH) Enterprise Value (2009 - 2026)
Bio-Techne's quarterly Enterprise Value came in at -$209.8 million in Q1 2026, down 49.16% year-on-year from -$412.7 million in Q1 2025, and down 21.37% quarter-over-quarter from -$172.9 million in Q4 2025.
Bio-Techne has reported Enterprise Value for 18 years, with the latest figure at -$209.8 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value fell 49.16% year-over-year to -$209.8 million; the trailing twelve-month figure through Mar 2026 stood at -$209.8 million (down 49.16% YoY), and the FY2025 full-year result was -$165.0 million, down 2.12% from the prior year.
- Enterprise Value for Q1 2026 stood at -$209.8 million, down from -$172.9 million in the prior quarter.
- The five-year high for Enterprise Value was -$135.7 million in Q4 2023, with the low at -$247.8 million in Q2 2022.
- Average Enterprise Value over 5 years is -$179.5 million, with a median of -$172.9 million recorded in 2025.
- Year-over-year, Enterprise Value surged 32.31% in 2023 and tumbled 49.16% in 2026.
- Tracing TECH's Enterprise Value over 5 years: stood at -$196.8 million in 2022, then jumped by 31.06% to -$135.7 million in 2023, then plunged by 33.26% to -$180.8 million in 2024, then gained by 4.37% to -$172.9 million in 2025, then declined by 21.37% to -$209.8 million in 2026.
- The last three Enterprise Value figures came in at -$209.8 million (Q1 2026), -$172.9 million (Q4 2025), and -$145.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn | -209.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -209.82 Mn |
| Dec 31, 2025 | -172.88 Mn |
| Sep 30, 2025 | -144.96 Mn |
| Jun 30, 2025 | -165.03 Mn |
| Mar 31, 2025 | -140.67 Mn |
| Dec 31, 2024 | -180.78 Mn |
| Sep 30, 2024 | -194.21 Mn |
| Jun 30, 2024 | -161.60 Mn |
| Mar 31, 2024 | -145.31 Mn |
| Dec 31, 2023 | -135.65 Mn |
| Sep 30, 2023 | -166.15 Mn |
| Jun 30, 2023 | -197.43 Mn |
| Mar 31, 2023 | -157.20 Mn |
| Dec 31, 2022 | -196.76 Mn |
| Sep 30, 2022 | -203.08 Mn |
| Jun 30, 2022 | -247.79 Mn |
| Mar 31, 2022 | -232.23 Mn |
| Dec 31, 2021 | -279.44 Mn |
| Sep 30, 2021 | -227.47 Mn |
| Jun 30, 2021 | -223.29 Mn |
| Mar 31, 2021 | -267.76 Mn |
| Dec 31, 2020 | -274.01 Mn |
| Sep 30, 2020 | -287.39 Mn |
| Jun 30, 2020 | -270.89 Mn |
| Mar 31, 2020 | -261.09 Mn |
| Dec 31, 2019 | -243.95 Mn |
| Sep 30, 2019 | -158.41 Mn |
| Jun 30, 2019 | -130.29 Mn |
| Mar 31, 2019 | -178.79 Mn |
| Dec 31, 2018 | -156.53 Mn |
| Sep 30, 2018 | -163.72 Mn |
| Jun 30, 2018 | -181.75 Mn |
| Mar 31, 2018 | -176.43 Mn |
| Dec 31, 2017 | -162.39 Mn |
| Sep 30, 2017 | -122.73 Mn |
| Jun 30, 2017 | -157.71 Mn |
| Mar 31, 2017 | -113.62 Mn |
| Dec 31, 2016 | -98.94 Mn |
| Sep 30, 2016 | -121.97 Mn |
| Jun 30, 2016 | -95.84 Mn |
| Mar 31, 2016 | -84.59 Mn |
| Dec 31, 2015 | -115.71 Mn |
| Sep 30, 2015 | -87.27 Mn |
| Jun 30, 2015 | -110.92 Mn |
| Mar 31, 2015 | -159.95 Mn |
| Dec 31, 2014 | -139.94 Mn |
| Sep 30, 2014 | -130.81 Mn |
| Jun 30, 2014 | -363.35 Mn |
| Mar 31, 2014 | -220.13 Mn |
| Dec 31, 2013 | -186.86 Mn |
| Sep 30, 2013 | -184.70 Mn |
| Jun 30, 2013 | -332.94 Mn |
| Mar 31, 2013 | -312.88 Mn |
| Dec 31, 2012 | -286.10 Mn |
| Sep 30, 2012 | -273.07 Mn |
| Jun 30, 2012 | -268.99 Mn |
| Mar 31, 2012 | -219.61 Mn |
| Dec 31, 2011 | -137.75 Mn |
| Sep 30, 2011 | -133.36 Mn |
| Jun 30, 2011 | -140.81 Mn |
| Mar 31, 2011 | -213.90 Mn |
| Dec 31, 2010 | -194.86 Mn |
| Sep 30, 2010 | -172.63 Mn |
| Jun 30, 2010 | -138.81 Mn |
| Mar 31, 2010 | -108.24 Mn |
| Dec 31, 2009 | -195.55 Mn |
| Sep 30, 2009 | -174.76 Mn |
| Jun 30, 2009 | -160.94 Mn |